Reproxalap Ophthalmic Solution (0.5%)

DRUG3 trials

Sponsors

Aldeyra Therapeutics, Inc.

Conditions

Allergic ConjunctivitisConjunctivitis, Allergic

Phase 1

A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis

CompletedNCT03660878

Aldeyra Therapeutics, Inc.Allergic Conjunctivitis

Start: 2018-09-08End: 2019-11-19Updated: 2025-04-08

A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber

CompletedNCT03709121

Aldeyra Therapeutics, Inc.Conjunctivitis, Allergic

Start: 2018-10-02End: 2019-03-20Updated: 2025-02-24

Phase 3

ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis

CompletedNCT03494504

Aldeyra Therapeutics, Inc.Allergic Conjunctivitis

Start: 2018-03-30End: 2018-11-05Updated: 2025-02-11